JPH08504751A - ビオチニル化した化学発光性標識、結合体、測定法及び測定法キット - Google Patents
ビオチニル化した化学発光性標識、結合体、測定法及び測定法キットInfo
- Publication number
- JPH08504751A JPH08504751A JP6506574A JP50657494A JPH08504751A JP H08504751 A JPH08504751 A JP H08504751A JP 6506574 A JP6506574 A JP 6506574A JP 50657494 A JP50657494 A JP 50657494A JP H08504751 A JPH08504751 A JP H08504751A
- Authority
- JP
- Japan
- Prior art keywords
- chemiluminescent
- biotin
- carbon
- compound according
- bound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000003556 assay Methods 0.000 title claims abstract description 42
- 238000003149 assay kit Methods 0.000 title claims description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N biotin Natural products N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims abstract description 79
- 150000001875 compounds Chemical class 0.000 claims abstract description 65
- 235000020958 biotin Nutrition 0.000 claims abstract description 45
- 229960002685 biotin Drugs 0.000 claims abstract description 44
- 239000011616 biotin Substances 0.000 claims abstract description 44
- 239000012491 analyte Substances 0.000 claims abstract description 41
- 238000002372 labelling Methods 0.000 claims abstract description 25
- 108010090804 Streptavidin Proteins 0.000 claims abstract description 15
- 108090001008 Avidin Proteins 0.000 claims abstract description 12
- 239000000126 substance Substances 0.000 claims description 33
- 229910052799 carbon Inorganic materials 0.000 claims description 28
- 238000000034 method Methods 0.000 claims description 28
- 230000009870 specific binding Effects 0.000 claims description 28
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 25
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 21
- 125000000524 functional group Chemical group 0.000 claims description 21
- 125000000623 heterocyclic group Chemical class 0.000 claims description 19
- 238000000691 measurement method Methods 0.000 claims description 14
- 229910052757 nitrogen Inorganic materials 0.000 claims description 13
- 238000004020 luminiscence type Methods 0.000 claims description 11
- 125000004432 carbon atom Chemical group C* 0.000 claims description 10
- 125000003118 aryl group Chemical group 0.000 claims description 9
- 229910052739 hydrogen Inorganic materials 0.000 claims description 9
- 239000001257 hydrogen Substances 0.000 claims description 9
- 125000000962 organic group Chemical group 0.000 claims description 9
- 230000002860 competitive effect Effects 0.000 claims description 8
- 150000002391 heterocyclic compounds Chemical class 0.000 claims description 8
- 150000001408 amides Chemical class 0.000 claims description 7
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 6
- 125000000217 alkyl group Chemical group 0.000 claims description 6
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims description 6
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 6
- DZBUGLKDJFMEHC-UHFFFAOYSA-O acridine;hydron Chemical compound C1=CC=CC2=CC3=CC=CC=C3[NH+]=C21 DZBUGLKDJFMEHC-UHFFFAOYSA-O 0.000 claims description 5
- 150000001413 amino acids Chemical class 0.000 claims description 5
- 150000001615 biotins Chemical class 0.000 claims description 5
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 5
- 238000001514 detection method Methods 0.000 claims description 5
- 230000007062 hydrolysis Effects 0.000 claims description 5
- 238000006460 hydrolysis reaction Methods 0.000 claims description 5
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 claims description 5
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 claims description 4
- 239000004472 Lysine Substances 0.000 claims description 4
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims description 4
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 238000005259 measurement Methods 0.000 claims description 4
- 229910052760 oxygen Inorganic materials 0.000 claims description 4
- 239000001301 oxygen Substances 0.000 claims description 4
- 125000001931 aliphatic group Chemical group 0.000 claims description 3
- 150000001721 carbon Chemical group 0.000 claims description 3
- 229910052736 halogen Inorganic materials 0.000 claims description 3
- 125000005842 heteroatom Chemical group 0.000 claims description 3
- 150000002431 hydrogen Chemical class 0.000 claims description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 3
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims description 3
- 150000003573 thiols Chemical class 0.000 claims description 3
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims description 2
- 238000002967 competitive immunoassay Methods 0.000 claims description 2
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 2
- 150000002367 halogens Chemical class 0.000 claims description 2
- 125000001905 inorganic group Chemical group 0.000 claims description 2
- 238000002156 mixing Methods 0.000 claims description 2
- 230000036963 noncompetitive effect Effects 0.000 claims description 2
- 238000010534 nucleophilic substitution reaction Methods 0.000 claims description 2
- 229940124530 sulfonamide Drugs 0.000 claims description 2
- 150000003456 sulfonamides Chemical class 0.000 claims description 2
- 229910052717 sulfur Inorganic materials 0.000 claims description 2
- 239000011593 sulfur Chemical group 0.000 claims description 2
- 150000003568 thioethers Chemical class 0.000 claims description 2
- 125000003275 alpha amino acid group Chemical group 0.000 claims 1
- 238000002405 diagnostic procedure Methods 0.000 claims 1
- 230000001939 inductive effect Effects 0.000 claims 1
- 235000021174 kaiseki Nutrition 0.000 abstract 1
- 238000006243 chemical reaction Methods 0.000 description 33
- 239000003153 chemical reaction reagent Substances 0.000 description 25
- 238000009739 binding Methods 0.000 description 21
- 239000007795 chemical reaction product Substances 0.000 description 18
- -1 hydroxy, mercapto Chemical class 0.000 description 13
- 239000000523 sample Substances 0.000 description 13
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 12
- 150000002148 esters Chemical class 0.000 description 12
- 230000015572 biosynthetic process Effects 0.000 description 11
- 230000027455 binding Effects 0.000 description 10
- 239000007790 solid phase Substances 0.000 description 10
- 239000002904 solvent Substances 0.000 description 9
- 239000000047 product Substances 0.000 description 8
- 125000001424 substituent group Chemical group 0.000 description 8
- 150000007970 thio esters Chemical class 0.000 description 8
- 238000003018 immunoassay Methods 0.000 description 7
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 6
- 239000000543 intermediate Substances 0.000 description 6
- 235000018102 proteins Nutrition 0.000 description 6
- 108090000623 proteins and genes Proteins 0.000 description 6
- 102000004169 proteins and genes Human genes 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- DZBUGLKDJFMEHC-UHFFFAOYSA-N acridine Chemical compound C1=CC=CC2=CC3=CC=CC=C3N=C21 DZBUGLKDJFMEHC-UHFFFAOYSA-N 0.000 description 5
- 239000000427 antigen Substances 0.000 description 5
- 102000036639 antigens Human genes 0.000 description 5
- 108091007433 antigens Proteins 0.000 description 5
- 238000005415 bioluminescence Methods 0.000 description 5
- 230000029918 bioluminescence Effects 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 150000002894 organic compounds Chemical class 0.000 description 5
- 101150047829 plin-1 gene Proteins 0.000 description 5
- 238000000159 protein binding assay Methods 0.000 description 5
- BAQMYDQNMFBZNA-UHFFFAOYSA-N N-biotinyl-L-lysine Natural products N1C(=O)NC2C(CCCCC(=O)NCCCCC(N)C(O)=O)SCC21 BAQMYDQNMFBZNA-UHFFFAOYSA-N 0.000 description 4
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 4
- 235000001014 amino acid Nutrition 0.000 description 4
- 229940024606 amino acid Drugs 0.000 description 4
- BAQMYDQNMFBZNA-MNXVOIDGSA-N biocytin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)NCCCC[C@H](N)C(O)=O)SC[C@@H]21 BAQMYDQNMFBZNA-MNXVOIDGSA-N 0.000 description 4
- 230000003301 hydrolyzing effect Effects 0.000 description 4
- 230000007246 mechanism Effects 0.000 description 4
- 239000000186 progesterone Substances 0.000 description 4
- 229960003387 progesterone Drugs 0.000 description 4
- 238000010791 quenching Methods 0.000 description 4
- 238000006467 substitution reaction Methods 0.000 description 4
- 239000000758 substrate Substances 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 3
- 239000011324 bead Substances 0.000 description 3
- 238000012875 competitive assay Methods 0.000 description 3
- 230000000295 complement effect Effects 0.000 description 3
- 108020004707 nucleic acids Proteins 0.000 description 3
- 102000039446 nucleic acids Human genes 0.000 description 3
- 150000007523 nucleic acids Chemical class 0.000 description 3
- 150000002978 peroxides Chemical class 0.000 description 3
- 230000000171 quenching effect Effects 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- UHIKCYUTOJHNNY-BVSLBCMMSA-N (3aS,4S,6aR)-4-(5-acridin-1-yl-5-oxopentyl)-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-2-one Chemical compound C1[C@H]2[C@@H]([C@@H](S1)CCCCC(=O)C3=CC=CC4=NC5=CC=CC=C5C=C43)NC(=O)N2 UHIKCYUTOJHNNY-BVSLBCMMSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid group Chemical group C(C1=CC=CC=C1)(=O)O WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 125000004057 biotinyl group Chemical group [H]N1C(=O)N([H])[C@]2([H])[C@@]([H])(SC([H])([H])[C@]12[H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C(*)=O 0.000 description 2
- 150000001732 carboxylic acid derivatives Chemical group 0.000 description 2
- 239000013626 chemical specie Substances 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 230000008025 crystallization Effects 0.000 description 2
- 125000004122 cyclic group Chemical group 0.000 description 2
- 229910001882 dioxygen Inorganic materials 0.000 description 2
- 238000006073 displacement reaction Methods 0.000 description 2
- 239000012156 elution solvent Substances 0.000 description 2
- 238000000855 fermentation Methods 0.000 description 2
- 230000004151 fermentation Effects 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 230000008105 immune reaction Effects 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000007899 nucleic acid hybridization Methods 0.000 description 2
- 238000007344 nucleophilic reaction Methods 0.000 description 2
- 239000012071 phase Substances 0.000 description 2
- RXNXLAHQOVLMIE-UHFFFAOYSA-N phenyl 10-methylacridin-10-ium-9-carboxylate Chemical compound C12=CC=CC=C2[N+](C)=C2C=CC=CC2=C1C(=O)OC1=CC=CC=C1 RXNXLAHQOVLMIE-UHFFFAOYSA-N 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 239000000376 reactant Substances 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 230000009257 reactivity Effects 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 230000002441 reversible effect Effects 0.000 description 2
- 150000003431 steroids Chemical class 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 230000001052 transient effect Effects 0.000 description 2
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
- 102000040650 (ribonucleotides)n+m Human genes 0.000 description 1
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 1
- XSXHTPJCSHZYFJ-MNXVOIDGSA-N 5-[(3as,4s,6ar)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]-n-[(5s)-5-amino-6-hydrazinyl-6-oxohexyl]pentanamide Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)NCCCC[C@H](N)C(=O)NN)SC[C@@H]21 XSXHTPJCSHZYFJ-MNXVOIDGSA-N 0.000 description 1
- HJCUTNIGJHJGCF-UHFFFAOYSA-N 9,10-dihydroacridine Chemical compound C1=CC=C2CC3=CC=CC=C3NC2=C1 HJCUTNIGJHJGCF-UHFFFAOYSA-N 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- KXDHJXZQYSOELW-UHFFFAOYSA-N Carbamic acid Chemical compound NC(O)=O KXDHJXZQYSOELW-UHFFFAOYSA-N 0.000 description 1
- 108020004414 DNA Proteins 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 239000003298 DNA probe Substances 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- NQTADLQHYWFPDB-UHFFFAOYSA-N N-Hydroxysuccinimide Chemical compound ON1C(=O)CCC1=O NQTADLQHYWFPDB-UHFFFAOYSA-N 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 241000186983 Streptomyces avidinii Species 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 125000004183 alkoxy alkyl group Chemical group 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 125000003368 amide group Chemical group 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- 239000003418 antiprogestin Substances 0.000 description 1
- 125000003710 aryl alkyl group Chemical group 0.000 description 1
- 150000007860 aryl ester derivatives Chemical class 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- 238000005815 base catalysis Methods 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 150000001559 benzoic acids Chemical class 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000008033 biological extinction Effects 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 239000008366 buffered solution Substances 0.000 description 1
- 150000001718 carbodiimides Chemical class 0.000 description 1
- HDFRDWFLWVCOGP-UHFFFAOYSA-N carbonothioic O,S-acid Chemical compound OC(S)=O HDFRDWFLWVCOGP-UHFFFAOYSA-N 0.000 description 1
- 150000001733 carboxylic acid esters Chemical class 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- 230000002925 chemical effect Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000010219 correlation analysis Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 229940061607 dibasic sodium phosphate Drugs 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 235000014103 egg white Nutrition 0.000 description 1
- 210000000969 egg white Anatomy 0.000 description 1
- 125000006575 electron-withdrawing group Chemical group 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 125000005448 ethoxyethyl group Chemical group [H]C([H])([H])C([H])([H])OC([H])([H])C([H])([H])* 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 235000014304 histidine Nutrition 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 238000006897 homolysis reaction Methods 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- SMWDFEZZVXVKRB-UHFFFAOYSA-O hydron;quinoline Chemical compound [NH+]1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-O 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 150000002484 inorganic compounds Chemical class 0.000 description 1
- 229910010272 inorganic material Inorganic materials 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 238000001471 micro-filtration Methods 0.000 description 1
- 150000002825 nitriles Chemical class 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- 230000000269 nucleophilic effect Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000000813 peptide hormone Substances 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000003623 progesteronic effect Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 239000000700 radioactive tracer Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000003746 solid phase reaction Methods 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 125000003944 tolyl group Chemical group 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- 150000003673 urethanes Chemical class 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 125000005023 xylyl group Chemical group 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Food Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Biotechnology (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1. ストレプタビジン又はアビジン複合体を形成するビオチン置換基を含有す る化学発光性標識化合物。 2. ストレプタビジン又はアビジン或いは分析物と複合化されたストレプタビ ジン又はアビジンと複合化された請求項1記載の化学発光性標識化合物。 3. 加水分解安定性を有する請求項1記載の化学発光性標識化合物。 4. 特異的結合用物質に結合された化学発光性標識を使用する分析物の検出の ための診断測定法において、標識が請求項1記載の化学発光性標識化合物である 診断測定法。 5. 特異的結合用物質に結合された請求項1記載の化学発光性標識よりなる化 学発光性標識付け結合体。 6. 測定法が競合型又は非競合型の免疫検定法である請求項4記載の診断測定 法。 7. ビオチン置換基が、塩基の存在下に過酸化水素と反応したときに化学ルミ ネセンスを発する能力を有するビオチニル置換複素環式部分を含有するビオチニ ル化標識化合物を形成する請求項1記載の化学発光性標識化合物。 8. 次式 (ここで、R1は2価の有機基であり、R2はビオチンの随意の基であり、存在ず るときは、これは少なくとも1個の炭素原子を含有する2価の部分であり、Ro は複素環式構造からなり、ビオチン又は置換ビオチンに直接結合している) を有する請求項1記載の化学発光性標識化合物。 9. R1が1〜約10個の炭素原子を含有する脂肪族基からなる請求項8記載 の化学発光性標識化合物。 10. R1が少なくとも5個の炭素原子を含有する脂肪族基からなる請求項9 記載の化学発光性標識化合物。 11. R2が少なくとも5個の炭素原子を含む請求項8記載の化学発光性標識 化合物。 12. R2がヘテロ原子を含む請求項11記載の化学発光性標識化合物。 13. ヘテロ原子が窒素又は酸素をからなる請求項12記載の化学発光性標識 化合物。 14. R2がビオチンを、ビオチン部分を含有する構造と反応する1個以上の 補足官能基を含有する化合物と求核置換することにより形成される反復単位から なる請求項8記載の化学発光性標識化合物。 15. 次式 (ここで、Aはビオチン部分であり、BはR1及び随意のR2であり、Cは化学発 光性を有する複素環式縮合環であり、RV、RW及びRXはそれぞれ水素、炭素に 結合したアミノ、炭素に結合したカルボキシ、炭素に結合したハロゲン、炭素に 結合したスルホニル、炭素に結合したヒドロキシル、炭素に結合したアミド、炭 素に結合したチオール又は場合いより炭素若しくは窒素に直接結合した1価の有 機基であり、Ryはアリール置換オキシ、アリール置換スルフィド部分、或いは 場合により酸素、硫黄若しくは窒素結合により隣接カルボニルに結合した有機置 換スルホンイミノ部分であり、Zのうちの一つは窒素であり、残りは炭素である 。ただし、RV、RW、RX及びRyの一つはR2(存在するならば)又はR1に直接 結合して結合A〜Cを形成し、また窒素であるZに結合するRVは炭素−窒素結 合によりその窒素に結合し、さらに場合により炭素に結合しているRVは一緒に なって芳香族縮合環構造を形成する) ビチオニル化複素環式構造を有する請求項8記載の化学発光性標識化合物。 16. 複素環式縮合環がアクリジニウム及びフェナントロリジニウムである請 求項15記載の化学発光性標識化合物。 17. 複素環式縮合環がアクリジニウムである請求項16記載の化学発光性標 識化合物。 18. 複素環式縮合環がフェナントロリジニウムである請求項16記載の化学 発光性標識化合物。 を有する請求項17記載の化学発光性標識化合物。 20. ビオチニル化複素環式構造が次式 (ここで、R2は存在するときはRa-eの一つに結合し、またR2が存在しないと きはカルボニルがRa-eの一つに結合し、Ra-eはそれぞれ水素、1〜約12個の 炭素原子を含有するアルキル、アリール又は縮合アリール(これによりビスアリ ール、ジシクロアリール、トリシクロアリール、5〜8個の炭素原子を含有する シクロアルキルを形成する)の一つ、或いは環の炭素に直接結合しているか又は 環に無機の若しくは有機の基を介して間接的に結合している官能基の一つであり 、その官能基はAのビオチンに場合によりR2を介して又はビオチン部分のカル ボニルを介して共有結合又はイオン結合している) を有する請求項19記載の化学発光性標識化合物。 21. 特異的結合用物質に結合させた化学発光性標識を 使用する分析物の検出のための請求項4記載の診断測定法において、請求項1記 載の化学発光性標識化合物を使用し、分析物を化学発光性標識付け特異的結合用 物質と混合し、結合体から解離する中間体の崩壊により化学ルミネセンスを誘発 させ、それからのルミネセンスを測定して分析物を定量することを特徴とする診 断測定法。 22. 化学発光性を有する標識付け複合体を入れた小びんを備え、標識の崩壊 により発生する化学ルミネセンスを測定することにより分析物を診断する診断測 定用キットにおいて、複合体が請求項2記載の複合体である診断測定用キット。 23. ビオチニル化複素環式構造が次式 を有する請求項19記載の化学発光性標識化合物。 24. ビオチニル化複素環式構造が次式 を有する請求項20記載の化学発光性標識化合物。 25. 官能性ビオチン含有化合物と化学発光性複素環式化合物との反応によっ てビオチニル化した化学発光性標識を製造する方法。 26. ビオチンがNHS置換化合物である請求項25記載の方法。 27. ビオチンが次式 の化合物の一つである請求項26記載の方法。 28. ビオチンがアミノ酸に結合される請求項25記載の方法。 29. アミノ酸がリジンである請求項28記載の方法。 30. リジンと反応されるビオチンが次式 を有する請求項29記載の方法。 31. 化学発光性複素環式化合物が次式 (ここで、各X1-3はビオチン含有化合物の官能基と反応できる官能基の一つ、 又は水素、又は1価の有機基であり、R’、R”及びRPは窒素及びスルホニル に炭素結合した2価の有機基である) の一つを有するスルホンアミドである請求項25記載の方法。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/933,478 US5395938A (en) | 1992-08-21 | 1992-08-21 | Biotinylated chemiluminescent labels and their conjugates, assays and assay kits |
US07/933,478 | 1992-08-21 | ||
PCT/US1993/007896 WO1994004538A1 (en) | 1992-08-21 | 1993-08-19 | Biotinylated chemiluminescent labels, conjugates, assays, assay kits |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH08504751A true JPH08504751A (ja) | 1996-05-21 |
JP4068137B2 JP4068137B2 (ja) | 2008-03-26 |
Family
ID=25464042
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP50657494A Expired - Lifetime JP4068137B2 (ja) | 1992-08-21 | 1993-08-19 | ビオチニル化した化学発光性標識、結合体、測定法及び測定法キット |
Country Status (12)
Country | Link |
---|---|
US (1) | US5395938A (ja) |
EP (1) | EP0656005B1 (ja) |
JP (1) | JP4068137B2 (ja) |
AT (1) | ATE238309T1 (ja) |
AU (1) | AU677017B2 (ja) |
CA (1) | CA2142867C (ja) |
DE (1) | DE69332903T2 (ja) |
ES (1) | ES2198417T3 (ja) |
FI (1) | FI111946B (ja) |
NO (1) | NO314308B1 (ja) |
NZ (1) | NZ255853A (ja) |
WO (1) | WO1994004538A1 (ja) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005536748A (ja) * | 2002-08-20 | 2005-12-02 | クエスト ダイアグノスティックス インヴェストメンツ インコーポレイテッド | 親水性化学発光アクリジニウムラベル化剤 |
US7824928B2 (en) | 2002-08-20 | 2010-11-02 | Quest Diagnostics Investments Incorporated | Hydrophilic chemiluminescent acridinium labeling reagents |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3750503T2 (de) * | 1986-10-22 | 1995-02-09 | Abbott Lab | Chemilumineszierende Acridinium- und Phenantridiniumsalze. |
US6087188A (en) * | 1992-11-13 | 2000-07-11 | Alk A/S | Two-site immunoassay for an antibody with chemiluminescent label and biotin bound ligand |
DE4407423A1 (de) * | 1994-03-05 | 1995-09-07 | Boehringer Mannheim Gmbh | Entstörmittel zum Einsatz bei Immunoassays |
GB2289334B (en) * | 1994-05-10 | 1998-08-26 | Molecular Light Technology Lim | Enzyme linked chemiluminescent assay |
US5663054A (en) | 1995-03-03 | 1997-09-02 | Abbott Laboratories | Determination of steroids by competitive immunoassay |
US6056923A (en) * | 1997-06-25 | 2000-05-02 | Clmp, Inc. | Dual injector for chemiluminescence immunoanalyzing system |
FR2781802B1 (fr) * | 1998-07-31 | 2001-05-11 | Bio Merieux | Derives satures ou insatures de l'abietane, conjugues derives et utilisations dans une composition diagnostique, un reactif et un dispositif |
KR20000074881A (ko) * | 1999-05-26 | 2000-12-15 | 황승용 | 마이크로웰을 이용한 디엔에이 돌연변이의 확인방법 및 키트 |
US7087395B1 (en) | 2001-01-16 | 2006-08-08 | Quest Diagnostics Investments Incorporated | Vitamin D assay |
US20030082179A1 (en) * | 2001-07-03 | 2003-05-01 | Hutchison James Scott | Parathyroid hormone antibodies and related methods |
US6723851B2 (en) * | 2001-10-31 | 2004-04-20 | Quest Diagnostics Investment Incorporated | Chemiluminescent compounds and use thereof |
US20050042632A1 (en) * | 2002-02-13 | 2005-02-24 | Sirna Therapeutics, Inc. | Antibodies having specificity for nucleic acids |
US7071311B2 (en) * | 2002-02-13 | 2006-07-04 | Sirna Therapeutics, Inc. | Antibodies having specificity for 2′-C-allyl nucleic acids |
US20050112586A1 (en) * | 2003-11-24 | 2005-05-26 | Roland Janzen | Method and composition for stabilizing liquid reagents |
KR100778633B1 (ko) | 2007-04-13 | 2007-11-28 | 성균관대학교산학협력단 | 비오틴과 비오틴-폴리에틸렌글리콜이 접합된 glp-1유도체, 이의 제조방법 및 이를 포함하는 약학 조성물 |
AU2014232782B2 (en) | 2013-03-15 | 2018-05-24 | Hycor Biomedical, Inc. | Device and associated methods for performing luminescence and fluorescence measurements of a sample |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4363759A (en) * | 1978-04-10 | 1982-12-14 | Miles Laboratories, Inc. | Chemiluminescent-labeled haptens and antigens |
US4656252A (en) * | 1980-01-24 | 1987-04-07 | Giese Roger W | Amidobiotin compounds useful in a avidin-biotin multiple layering process |
DE3279029D1 (en) * | 1981-12-11 | 1988-10-20 | Welsh Nat School Med | Luminescent labelling materials and procedures |
US4687747A (en) * | 1984-07-02 | 1987-08-18 | Mallinckrodt, Inc. | Phenanthridinium ester as a labelling compound in luminometric immunoassay |
DE3601031A1 (de) * | 1986-01-16 | 1987-07-23 | Behringwerke Ag | Maleimido-derivate von biotin-hydrazid, verfahren zu ihrer herstellung und ihre verwendung |
US4709037A (en) * | 1987-02-17 | 1987-11-24 | Hoechst Celanese Corporation | Biotinylating agents |
US5180828A (en) * | 1990-02-09 | 1993-01-19 | Molecular Devices Corporation | Chromophoric reagents for incorporation of biotin or other haptens into macromolecules |
DE473984T1 (de) * | 1990-09-07 | 1992-08-13 | The Board Of Governors Of Wayne State University, Detroit, Mich. | 1,2-dioxetan-verbindungen als chemilumineszierende markierungen fuer organische und biologische molekuele. |
US5162352A (en) * | 1991-08-22 | 1992-11-10 | E. R. Squibb & Sons, Inc. | 7-oxabicycloheptyl substituted heterocyclic amide prostaglandin analogs |
-
1992
- 1992-08-21 US US07/933,478 patent/US5395938A/en not_active Expired - Lifetime
-
1993
- 1993-08-19 NZ NZ255853A patent/NZ255853A/en not_active IP Right Cessation
- 1993-08-19 CA CA2142867A patent/CA2142867C/en not_active Expired - Lifetime
- 1993-08-19 DE DE69332903T patent/DE69332903T2/de not_active Expired - Lifetime
- 1993-08-19 ES ES94908153T patent/ES2198417T3/es not_active Expired - Lifetime
- 1993-08-19 AT AT94908153T patent/ATE238309T1/de not_active IP Right Cessation
- 1993-08-19 WO PCT/US1993/007896 patent/WO1994004538A1/en active IP Right Grant
- 1993-08-19 EP EP94908153A patent/EP0656005B1/en not_active Expired - Lifetime
- 1993-08-19 JP JP50657494A patent/JP4068137B2/ja not_active Expired - Lifetime
- 1993-08-19 AU AU50864/93A patent/AU677017B2/en not_active Expired
-
1995
- 1995-02-20 FI FI950764A patent/FI111946B/fi not_active IP Right Cessation
- 1995-02-20 NO NO19950632A patent/NO314308B1/no not_active IP Right Cessation
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005536748A (ja) * | 2002-08-20 | 2005-12-02 | クエスト ダイアグノスティックス インヴェストメンツ インコーポレイテッド | 親水性化学発光アクリジニウムラベル化剤 |
US7824928B2 (en) | 2002-08-20 | 2010-11-02 | Quest Diagnostics Investments Incorporated | Hydrophilic chemiluminescent acridinium labeling reagents |
JP4699756B2 (ja) * | 2002-08-20 | 2011-06-15 | クエスト ダイアグノスティックス インヴェストメンツ インコーポレイテッド | 親水性化学発光アクリジニウムラベル化剤 |
US8034636B2 (en) | 2002-08-20 | 2011-10-11 | Quest Diagnostics Investments Incorporated | Hydrophilic chemiluminescent acridinium labeling reagents |
Also Published As
Publication number | Publication date |
---|---|
EP0656005A4 (en) | 1995-07-26 |
EP0656005B1 (en) | 2003-04-23 |
NZ255853A (en) | 1997-05-26 |
ES2198417T3 (es) | 2004-02-01 |
CA2142867A1 (en) | 1994-03-03 |
FI111946B (fi) | 2003-10-15 |
FI950764L (fi) | 1995-04-20 |
DE69332903D1 (de) | 2003-05-28 |
JP4068137B2 (ja) | 2008-03-26 |
AU677017B2 (en) | 1997-04-10 |
ATE238309T1 (de) | 2003-05-15 |
EP0656005A1 (en) | 1995-06-07 |
US5395938A (en) | 1995-03-07 |
AU5086493A (en) | 1994-03-15 |
FI950764A0 (fi) | 1995-02-20 |
NO950632D0 (no) | 1995-02-20 |
NO314308B1 (no) | 2003-03-03 |
CA2142867C (en) | 2010-03-16 |
WO1994004538A1 (en) | 1994-03-03 |
NO950632L (no) | 1995-04-07 |
DE69332903T2 (de) | 2004-03-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0108399B1 (en) | Substituted carboxyfluoresceins | |
JPH08504751A (ja) | ビオチニル化した化学発光性標識、結合体、測定法及び測定法キット | |
US5281712A (en) | Ammonium substituted chemiluminescent labels and their conjugates, and assays therefrom | |
US4668640A (en) | Fluorescence polarization immunoassay utilizing substituted carboxyfluoresceins | |
EP0110186A1 (en) | Aminomethylfluorescein derivatives | |
GB2111476A (en) | Substituted carboxy- fluoresceins and their use in fluorescence polarization immunoassay | |
JPH0210382B2 (ja) | ||
EP0170415B1 (en) | Phenanthridinium ester as a labelling compound in luminometric immunoassay | |
JPH0137693B2 (ja) | ||
JPH0816103B2 (ja) | 化学発光性アクリジニウム塩 | |
JP2002518410A (ja) | 新規な化学発光標識化合物 | |
US5521319A (en) | Biotinylation reagent and method of use thereof | |
GB2045239A (en) | Intermediates useful in the synthesis of chemiluminescent- labeled conjugates for use in specific binding assays | |
EP1119554A1 (en) | Xanthan-ester and acridan substrates for horseradish peroxidase | |
GB2026158A (en) | Chemiluminescent naphthalene - 1,2 - dicarboxylic acid hydrazide-labelled conjugates | |
US5338847A (en) | Hydrolytically stable chemiluminescent labels and their conjugates, and assays therefrom by adduct formation | |
US5066426A (en) | Fluorescence polarization immunoassay utilizing substituted carboxyfluoresceins | |
JP4699756B2 (ja) | 親水性化学発光アクリジニウムラベル化剤 | |
JP3248628B2 (ja) | 化学発光性化合物およびこれを用いるアッセイ法 | |
EP0108403A2 (en) | Substituted carboxyfluoresceins | |
JP3325370B2 (ja) | 化学発光性化合物およびこれを用いるアッセイ法 | |
JP3174729B2 (ja) | アクリジン誘導体、その製法およびこれを用いた標識法 | |
JPH06316599A (ja) | ジフェンヒドラミンおよびその代謝産物の免疫学的測定のための組成物および方法 | |
US20040214217A1 (en) | Chemiluminescent compounds and use thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20040107 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20040223 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20040407 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20051213 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20060413 |
|
A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20060615 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20070524 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20070824 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20070829 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20071122 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20071218 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20080110 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110118 Year of fee payment: 3 |
|
R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110118 Year of fee payment: 3 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120118 Year of fee payment: 4 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130118 Year of fee payment: 5 |
|
EXPY | Cancellation because of completion of term |